Validating and Applying Vaccine Investment Tools (Global)
Through previous grants, WDI developed two proof-of-concept tools for evaluating and prioritizing investments in vaccine-related technologies. The Health Investment Prioritization (HIP) Coverage tool estimates changes in vaccination coverage rates by quantifying how well a vaccine presentation addresses technology-addressable barriers to vaccination. The HIP-Valuation tool uses a cost-benefit analysis structure to identify a price window acceptable to both vaccine buyers and sellers, if such a price window exists. In the current project, funded by the Bill & Melinda Gates Foundation, WDI seeks to build on the progress to date by using these tools to answer the real-world questions of global health donors and country partners.
The first phase of the project is to validate the HIP tools through an external committee of academics and global health donors. Once validated, WDI will apply the tools to technologies such as microarray patches and thermostable formulations. In a final phase of the project, WDI will identify potential long-term users of the HIP tools and explore options for creating a version of the tools customized to user needs.